NanoVibronix (NAOV) said Friday it completed its acquisition of privately-held ENvue Medical Holdings in a stock-for-stock transaction.
Under the deal, all of ENvue's outstanding equity interests were exchanged based on a fixed exchange ratio for consideration as a combination of about 1.7 million NanoVibronix common shares and 57,720 shares of series X non-voting convertible preferred stock, NanoVibronix said.
The company said that after the completion of the deal, a successor-in-interest of ENvue will be a wholly-owned unit of NanoVibronix.
The company also said concurrently with the deal's closing, it sold a $500,000 senior convertible debenture in a private placement.
NanoVibronix shares were up nearly 2% in recent trading.
Price: 0.48, Change: +0.01, Percent Change: +1.93
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。